PCAST Begins Its Work By Focusing On Industry

WASHINGTON -- On March 22 the President's Council of Advisers on Science and Technology rolled up its sleeves and got down to business, namely, the task of getting United States industry to play a larger role in strengthening science. The council has a mandate to provide the president with all manner of scientific and technological advice on pressing issues of the day. And its 12 members, who were sworn in February 2 (The Scientist, March 5, 1990, page 3), represent a diverse elite, from billi

Written byJeffrey Mervis
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

WASHINGTON -- On March 22 the President's Council of Advisers on Science and Technology rolled up its sleeves and got down to business, namely, the task of getting United States industry to play a larger role in strengthening science.

The council has a mandate to provide the president with all manner of scientific and technological advice on pressing issues of the day. And its 12 members, who were sworn in February 2 (The Scientist, March 5, 1990, page 3), represent a diverse elite, from billionaire electronics giant David Packard to academic molecular biologist and Nobel laureate David Nathans. But it was clear during last month's meeting, which featured presentations on high performance computing and materials science, that PCAST chairman and presidential science adviser Allan Bromley is intent on tapping the nation's private sector for timely advice on how to improve the state of the scientific enterprise.

One of Bromley's innovations ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Graphic of amino acid chains folded into proteins

Expi293™ PRO Expression System: Higher Yields Across a Wider Variety of Proteins

Thermo Fisher Logo